Abstract
The purpose of study was an assessment of the incidence and mortality rates for kidney, prostate and bladder cancer in the Amur region of the Far Eastern Federal District. Material and methods. Incidence and mortality rates for kidney, prostate and bladder cancer, cancer registry data, and ten-year follow-up data were used. Results . During the period 2007–16, the incidence and mortality rates for kidney, prostate and bladder cancer steadily increased in the Amur region. The trends in the morbidity and mortality were determined for all groups of the study population. The quality of the service activity indicated by the index of reliability of patients’ registry was estimated. As a prognostic test, the values of «disease severity» («disease burden») were studied. Based on these values, the assumptions about the most favorable prognosis and quality of life in patients with kidney cancer relative to patients with prostate and bladder cancers were made. Conclusion. The cancer incidence and mortality rates still remain high and the number of cases continues to increase in the Amur region. The results of the study were recommended by the authors for the practical use in the cancer services of the Amur Region for the development of targeted medical, social and economic programs.
Highlights
Эпидемиологические ИССЛЕДОВАНИЯ all groups of the study population
The purpose of study was an assessment of the incidence and mortality rates for kidney, prostate and bladder cancer in the Amur region of the Far Eastern Federal District
During the period 2007–16, the incidence and mortality rates for kidney, prostate and bladder cancer steadily increased in the Amur region
Summary
Абсолютное число заболевших Заболеваемость на 100 000 населения (стандартизованный показатель) Распределение больных по стадиям: I–II стадия III стадия IV стадия Неустановленная стадия Состоящие на учете на конец года Населения) Состоящие на учете 5 и более лет Летальность на первом году с момен‐ та установления диагноза Абсолютное число умерших Смертность на 100 000 населения (стандартизованный показатель) Верификация диагноза Мужчины/женщины, %. Число больных (3,0 %) с неустановленной стадией заболевания (РФ – 1,9 %) значительно выше, чем при раке предстательной железы (0,7 %) и раке мочевого пузыря (1,1 %). Живущих 5 лет и более после установления диагноза, составила 58,7 %, что отражает растущую положительную динамику начиная с 2007 г. Показатели индикатора «тяжести заболевания» у онкоурологических больных в Амурской области
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
